The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Asim Amin, Hans Hammers
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2019-01-01
Серии:Frontiers in Immunology
Предметы:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
Online-ссылка:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы